Skip to Content

THIS END UP DEPAKOTE SPRINKLE 125MG (Divalproex sodium delayed-release (sprinkle) 125 mg)

Pill with imprint THIS END UP DEPAKOTE SPRINKLE 125MG is Blue / White, Capsule-shape and has been identified as Divalproex sodium delayed-release (sprinkle) 125 mg. It is supplied by Sandoz Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; cyclothymic disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for THIS END UP DEPAKOTE SPRINKLE 125MG

Divalproex sodium delayed-release (sprinkle)

Imprint:
THIS END UP DEPAKOTE SPRINKLE 125MG
Strength:
125 mg
Color:
Blue / White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Inc.
National Drug Code (NDC):
00781-2243

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide